Type II NKT cells can induce TGF-β secretion from MDSCs by producing IL-13 [97–99], and blocking IL-13 or TGF-β.Eliminating NKT or myeloid cells may interrupt this immunosuppressive circuit and uncover immune surveillance to prevent tumor recurrence [97] (Fig. 1). This evidence concerns the gene IL13 and neoplasm.